Loading…
Loading…
Home › All recalls › Prescription medicine
Category
Prescription drugs recalled for contamination, potency or labelling.
Or try another category
2,003 recalls · newest first
Superpotent drug: Assay results were slightly above specification at the time zero point.
Presence of Particulate Matter; identified as glass
Presence of particulate matter: glass
Chemical Contamination: presence of benzene
Why this is here: It was found to contain a drug or chemical that is not on the label. That is different from an allergen or a contamination scare: anyone taking it has been taking a substance nobody prescribed, in an unknown dose, and it can interact with medication they are already on. Follow the agency notice rather than judging it by how the product looks.
Presence of Particulate Matter; identified as glass
Presence of Particulate Matter; identified as glass
CGMP Deviations: N-Nitroso Desloratadine impurity result exceeded the acceptable intake limit.
Presence of Foreign Tablets/Capsules: One 0.5 mg Tacrolimus capsule found in a bottle of 1 mg Tacrolimus capsules.
Failed Release Testing: Coarse Particle Mass for umeclidinium Out of Specification
Labeling: Label Error on Declared Strength: Assay value on the label is incorrect.
Labeling: Label Error on Declared Strength: Assay value on the label is incorrect.
CGMP Deviations: Inadequate line clearance which may result in a potential comingling of product.
Labeling: Label Error on Declared Strength: Assay value on the label is incorrect.
Labeling: Label Error on Declared Strength: Assay value on the label is incorrect.
Failed Impurities/Degradation Specifications: Out of specification Impurity C (4,5-desisopropylidene topiramate) result observed during routine…
Failed Impurities/Degradation Specifications
STAQ Pharma Inc.
Lack of assurance of sterility.
Presence of Particulate Matter.
Crystallization: bottles of Sandimmune Oral Solution were determined to contain crystals